Scilex Holding (SCLX) Notes Payables (2020 - 2025)

Scilex Holding (SCLX) recorded quarterly Notes Payables of $800000.0 in Q3 2025, down 95.92% quarter-over-quarter from $19.6 million in Q4 2021.

Scilex Holding (SCLX) Notes Payables (2020 - 2025) Analysis & Trends

Scilex Holding's Notes Payables history runs 3 years deep, the most recent figure standing at $800000.0 for Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $800000.0 (changed N/A YoY), while the FY2021 annual figure was $19.6 million, up 15586.4% from the prior year.
Notes Payables was $800000.0 for Q3 2025 at Scilex Holding, down from $19.6 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $19.6 million in Q4 2021 to a low of $800000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,026,132.38 Bn	93,026,127.42 Bn	7.76 Bn
2	Eli Lilly	1,022.62 Bn	1,017.34 Bn	16.22 Bn
3	Johnson & Johnson	570.65 Bn	548.59 Bn	15.96 Bn
4	AbbVie	398.73 Bn	389.38 Bn	10.78 Bn
5	Merck	295.53 Bn	289.88 Bn	12.09 Bn
6	Amgen	186.30 Bn	174.26 Bn	5.87 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn
8	Pfizer	146.09 Bn	133.32 Bn	-1.21 Bn
9	Bristol Myers Squibb	114.98 Bn	104.53 Bn	8.07 Bn
10	Scilex Holding	48.31 Mn	-101.62 Mn	4.15 Mn

Download Data